Table 3.
Characteristics of the bHPA- and iHPA-Negative Patients
Patients | bHPA | iHPA | Tumor stage | Status | Survival time (months) | Metastases |
---|---|---|---|---|---|---|
1 | Negative | Negative | IA | Alive | 64 | n.d.* |
2 | Negative | Negative | IA | Alive | 102 | n.d. |
3 | Negative | Negative | IA | Alive | 113,5 | n.d. |
4 | Negative | Negative | IA | Alive | 66 | n.d. |
5 | Negative | Negative | IB | Alive | 88 | Yes† |
6 | Negative | Negative | IB | Alive | 113 | n.d. |
7 | Negative | Positive | IA | Alive | 60 | n.d. |
8 | Negative | Positive | IA | Alive | 97 | n.d. |
9 | Negative | Positive | IIB | Deceased‡ | 97 | Yes‡ |
*n.d., not detectable.
†A single metastasis in the bone occurred after 66 months, it is still unclear if this was a late metastasis from the lung cancer or a metastasis from another cancer of unknown primary site.
‡Patient died of metastases of a secondary malignancy (small cell lung cancer) which occurred after 94 months of the diagnosis of a primary adenocarcinoma of the lung.